Replies to post #192479 on NorthWest Biotherapeutics Inc (NWBO)

[marzan]

There are 70m people in the US alone with Tg> 150.If Amarin captures 2m of them, the revenue is close to 5B a year while prescription revenue per patient is $2400/Yes. 10 times is 50B. Float is 330m
So pops will be min $150.I have 10s of thousands of shares and 100s of calls. The Street was skeptical that fish oil won't help heart attack. It is skeptical dc cells won't help cancer either. They going to be wrong again